Epidemiology and prospects for prevention of rotavirus disease in India

Indian Pediatrics

Volumn 49, Issue 6, 2012, Pages 467-474

  Kahn, G ^a   Fitzwater, S ^a   Tate, J ^b   Kang, G ^c   Ganguly, N ^d   Nair, G ^e   Steele, D ^f   Arora, R ^g   Chawlasarkar, M ^e   Parashar, U ^b   Santosham, M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d Translational Health Science and Technology Institute   (India)

^e NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^f PATH   (United States)

^g INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Epidemiology; Rotavirus; Serotype distribution; Vaccine

Indexed keywords

BOVINE HUMAN REASSORTANT ROTAVIRUS VACCINE; LIVE ATTENUATED LAMB ROTAVIRUS VACCINE; ROTAVIRUS VACCINE; SERIALLY PASSAGED HUMAN NEONATAL ROTAVIRUS STRAIN VACCINE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; CHILDHOOD MORTALITY; COST EFFECTIVENESS ANALYSIS; DEHYDRATION; DEVELOPING COUNTRY; DIARRHEA; DISEASE SURVEILLANCE; DRUG COST; DRUG EFFICACY; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; ENVIRONMENTAL SANITATION; GASTROENTERITIS; GENETIC VARIABILITY; HUMAN; IMMUNOGENICITY; INCIDENCE; INDIA; INFECTION PREVENTION; INTUSSUSCEPTION; NEWBORN INFECTION; ORAL REHYDRATION THERAPY; REVIEW; ROTAVIRUS INFECTION; SEASONAL VARIATION; SEROTYPE; SYSTEMATIC REVIEW; VACCINATION; VOMITING;

CHILD, PRESCHOOL; HUMANS; INDIA; INFANT; INFANT, NEWBORN; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84866043296     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-012-0076-7     Document Type: Review

References (69)

1. Bassani DG, Kumar R, Awasthi S, Morris SK, Paul VK, Shet A, et al. Causes of neonatal and child mortality in India: a nationally representative mortality survey. Lancet. 2010;376:1853-60.
2. Tate JE, Chitambar S, Esposito DH, Sarkar R, Gladstone B, Ramani S, et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine. 2009;27:F18-24.
3. Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011;365:337-46.
4. Bahl R, Ray P, Subodh S, Shambharkar P, Saxena M, Parashar U, et al. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis. 2005;192:S114-9.
5. Kelkar SD, Purohit SG, Simha KV. Prevalence of rotavirus diarrhoea among hospitalized children in Pune, India. Indian J Med Res. 1999;109:131-5.
6. Kelkar SD, Purohit SG, Boralkar AN, Verma SP. Prevalence of rotavirus diarrhea among outpatients and hospitalized patients: a comparison. Southeast Asian J Trop Med Public Health. 2001;32:494-9.
7. Saravanan P, Ananthan S, Ananthasubramanian M. Rotavirus infection among infants and young children in Chennai, South India. Indian J Med Microbiol. 2004;22:212-21.
8. Kang G, Green J, Gallimore CI, Brown DW. Molecular epidemiology of rotaviral infection in South Indian children with acute diarrhea from 1995-1996 to 1998-1999. J Med Virol. 2002;67:101-5.
9. Das S, Sen A, Uma G, Varghese V, Chaudhuri S, Bhattacharya SK, et al. Genomic diversity of group A rotavirus strains infecting humans in eastern India. J Clin Microbiol. 2002;40:146-9.
10. Banerjee I, Ramani S, Primrose B, Moses P, Iturriza- Gomara M, Gray JJ, et al. Comparative study of the epidemiology of rotavirus in children from a communitybased birth cohort and a hospital in South India. J Clin Microbiol. 2006;44:2468-74.
11. Samajdar S, Varghese V, Barman P, Ghosh S, Mitra U, Dutta P, et al. Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J Clin Virol. 2006;36:183-8.
12. Mishra V, Awasthi S, Nag VL, Tandon R. Genomic diversity of group A rotavirus strains in patients aged 1-36 months admitted for acute watery diarrhoea in northern India: a hospital-based study. Clin Microbiol Infect. 2010;16:45-50.
13. Samajdar S, Ghosh S, Chawla-Sarkar M, Mitra U, Dutta P, Kobayashi N, et al. Increase in prevalence of human group A rotavirus G9 strains as an important VP7 genotype among children in eastern India. J Clin Virol. 2008;43:334-9.
14. Chakravarti A, Chauhan MS, Sharma A, Verma V. Distribution of human rotavirus G and P genotypes in a hospital setting from Northern India. Southeast Asian J Trop Med Public Health. 2010;41:1145-52.
15. Kang G, Arora R, Chitambar SD, Deshpande J, Gupte MD, Kulkarni M, et al. Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged
16. Mukherjee A, Chattopadhyay S, Bagchi P, Dutta D, Singh NB, Arora R, et al. Surveillance and molecular characterization of rotavirus strains circulating in Manipur, north-eastern India: increasing prevalence of emerging G12 strains. Infect Genet Evol. 2010;10:311-20.
17. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304-6.
18. Ramani S, Kang G. Burden of disease & molecular epidemiology of group A rotavirus infections in India. Indian J Med Res. 2007;125:619-32.
19. Cicirello HG, Das BK, Gupta A, Bhan MK, Gentsch JR, Kumar R, et al. High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J. 1994;13:720-4.
20. Vethanayagam RR, Ananda Babu M, Nagalaxmi KS, Maiya PP, Venkatesh HA, Purohit S, et al. Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999. J Infect Dis. 2004;189:2282-9.
21. Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis. 1993;168:282-7.
22. Ramani S, Sowmyanarayanan TV, Gladstone BP, Bhowmick K, Asirvatham JR, Jana AK, et al. Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India. Pediatr Infect Dis J. 2008;27:719-23.
23. Banerjee I, Gladstone BP, Le Fevre AM, Ramani S, Iturriza-Gomara M, Gray JJ, et al. Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis. 2007;195:625-32.
24. Broor S, Ghosh D, Mathur P. Molecular epidemiology of rotaviruses in India. Indian J Med Res. 2003;118:59-67.
25. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med. 1983;309:72-6.
26. Chitambar SD, Tatte VS, Dhongde R, Kalrao V. High frequency of rotavirus viremia in children with acute gastroenteritis: discordance of strains detected in stool and sera. J Med Virol. 2008;80:2169-76.
27. Ray P, Sharma S, Agarwal RK, Longmei K, Gentsch JR, Paul VK, et al. First detection of G12 rotaviruses in newborns with neonatal rotavirus infection at all India Institute of Medical Sciences, New Delhi, India. J Clin Microbiol. 2007;45:3824-7.
28. Phukan AC, Patgiri DK, Mahanta J. Rotavirus associated acute diarrhoea in hospitalized children in Dibrugarh, north-east India. Indian J Pathol Microbiol. 2003;46: 274-8.
29. Nair GB, Ramamurthy T, Bhattacharya MK, Krishnan T, Ganguly S, Saha DR, et al. Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India. Gut Pathog. 2010;2:4.
30. Das S, Varghese V, Chaudhuri S, Barman P, Kojima K, Dutta P, et al. Genetic variability of human rotavirus strains isolated from Eastern and Northern India. J Med Virol. 2004;72:156-61.
31. Jain V, Das BK, Bhan MK, Glass RI, Gentsch JR. Great diversity of group A rotavirus strains and high prevalence of mixed rotavirus infections in India. J Clin Microbiol. 2001;39:3524-9.
32. Sharma S, Ray P, Gentsch JR, Glass RI, Kalra V, Bhan MK. Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007. J Clin Microbiol. 2008;46:1343-8.
33. Sharma S, Paul VK, Bhan MK, Ray P. Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain in Delhi, India. J Clin Microbiol. 2009;47:3998-4005.
34. Tatte VS, Gentsch JR, Chitambar SD. Characterization of group A rotavirus infections in adolescents and adults from Pune, India: 1993-1996 and 2004-2007. J Med Virol. 2010;82:519-27.
35. Zade JK, Chhabra P, Chitambar SD. Characterization of VP7 and VP4 genes of rotavirus strains: 1990-1994 and 2000-2002. Epidemiol Infect. 2009;137:936-42.
36. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29-56.
37. Nelson EA, Bresee JS, Parashar UD, Widdowson MA, Glass RI. Rotavirus epidemiology: the Asian Rotavirus Surveillance Network. Vaccine. 2008;26:3192-6.
38. Iturriza Gomara M, Kang G, Mammen A, Jana AK, Abraham M, Desselberger U, et al. Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol. 2004;42:2541-7.
39. Chandran A, Fitzwater S, Zhen A, Santosham M. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics. 2010;4:213-29.
40. National Family Health Survey (NFHS-3), 2005-06: India: Volume I. Mumbai: IIPS; 2007.
41. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200:S9-S15.
42. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
43. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
44. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics. 2010;126: e506-12.
45. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, et al. Decline in Rotavirus Hospitalizations and Health Care Visits for Childhood Diarrhea Following Rotavirus Vaccination in El Salvador. Pediatr Infect Dis J. 2010 Nov 2.
46. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ. 2010;340:c2825.
47. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362: 289-98.
48. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-63.
49. Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine. 2009;27:5936-41.
50. Muhsen K, Chodick G, Goren S, Shalev V, Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community. Vaccine. 2010;29:91-4.
51. Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011;30:S1-5.
52. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis. 2010;201:1617-24.
53. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in EI salvador. Pediatr Infect Dis J. 2011;30:S6-S10.
54. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J. 2010;29:319-23.
55. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299-305.
56. Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis. 2011;15:e206-10.
57. Soares-Weiser K, Maclehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2010:CD008521.
58. WHO. Rotavirus vaccine and intussusception. Weekly epidemiological record. 2011;86:38-40.
59. Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med. 2010;362:314-9.
60. Bhandari N, Sharma P, Glass RI, Ray P, Greenberg H, Taneja S, et al. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine. 2006;24:5817-23.
61. Bhandari N, Sharma P, Taneja S, Kumar T, Rongsen- Chandola T, Appaiahgari MB, et al. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, doubleblind, placebo-controlled trial. J Infect Dis. 2009;200:421-9.
62. Clements-Mann ML, Dudas R, Hoshino Y, Nehring P, Sperber E, Wagner M, et al. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine. 2001;19:4676-84.
63. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13:926-39.
64. Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines. 2010;9:395-407.
65. Moon KB. Differential rotavirus antibody profiles in breast milk specimens from mothers with infants in developed and developing countries. American Society for Virology Conference Vancouver, BC, Canada. 2009 Oct.
66. Goveia MG, DiNubile MJ, Dallas MJ, Heaton PM, Kuter BJ. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J. 2008;27:656-8.
67. Esposito DH, Tate JE, Kang G, Parashar UD. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008. Clin Infect Dis. 2011;52:171-7.
68. Rose J, Hawthorn RL, Watts B, Singer ME. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ. 2009;339:b3653.
69. Press Release - Bharat Biotech announces the price of Rotavac. Bharat Biotech. June 6, 2011. http://www.bharatbiotech.com/BBIL-GAVI- ROTAVACPress%20Release-06June2011-F.pdf.